Follow the people · Insider

RH

Robert Hershberg

Insider · Director · ADPT

Robert Hershberg files insider transactions with the SEC as a director of Adaptive Biotechnologies (ADPT). We hold 2 disclosed purchases and sales filed since 23 January 2006, 2 of them in the last 90 days.

  • Files forADPT
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure20 August 2026

Positions held

8 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 13 February 202018 August 2026Director · Adaptive Biotechnologies (ADPT)68 Form 4 lines · source: SEC Form 4
  • Filed 5 November 20257 July 2026Director · AtaiBeckley (ATAI)10 Form 4 lines · source: SEC Form 4
  • Filed 15 April 202117 June 2026Director · Recursion Pharmaceuticals (RXRX)20 Form 4 lines · source: SEC Form 4
  • Filed 1 February 202317 September 2025President and CEO · HilleVax (HLVX)8 Form 4 lines · source: SEC Form 4
  • Filed 1 May 20206 June 2023Director · Fate Therapeutics (FATE)8 Form 4 lines · source: SEC Form 4
  • Filed 3 December 202010 June 2022Director · Silverback Therapeutics (SBTX)3 Form 4 lines · source: SEC Form 4
  • Filed 2 March 201518 April 2022Director · NanoString Technologies (NSTG)71 Form 4 lines · source: SEC Form 4
  • Filed 31 January 200519 January 2006Sr. VP & Chief Medical Officer · Dendreon (DNDN)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.